302P: Phase II study of the efficacy and safety of BNT327/PM8002 plus systemic chemotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC)

作者：Y. Cheng, Jing Shi, Xue Meng, Li‐Yue Sun, Da Lv, Xiaolong Li, Yunfeng Pan, Jian Fang, Junru Chen, Xueling Qi, Bing Liu, Peng Zhang · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/s1556-0864(25)00494-0 · 被引用次数：6 · 研究领域：Lung Cancer Research Studies、Peptidase Inhibition and Analysis、Cancer therapeutics and mechanisms